Aditxt Appoints Corinne Pankovcin as President and Thomas J. Farley as Chief Financial Officer as Company Prepares for Global Commercialization
September 27 2021 - 8:45AM
Business Wire
Aditxt, Inc. (“Aditxt, or the “Company”). (Nasdaq: ADTX), a
biotech innovation company with a mission to improve the health of
the immune system, today announced key executive management changes
to support its growth plans. Corinne Pankovcin, who has served as
CFO of Aditxt, has been appointed as President and will work
closely with the Company’s CEO, Amro Albanna, to execute Aditxt’s
business strategy. Thomas J. Farley, who has served as Controller
and Principal Accounting Officer of Aditxt, has been appointed as
CFO.
As CFO of Aditxt since July 2020, Ms. Pankovcin, along with the
Company’s CEO and executive team, has effectively managed the
Company’s growth as it became publicly traded on Nasdaq.
Previously, she served as CFO and Treasurer of world-class
organizations including Business Development Corporation of America
and Blackrock Capital Investment Corporation (Nasdaq: BKCC), as
well as Managing Director of Finance at BlackRock Investment
Management LLC. Prior to joining BlackRock, Ms. Pankovcin was CFO
for the Global Emerging Markets products group at AIG Capital
Partners. Ms. Pankovcin began her career with
PricewaterhouseCoopers LLP, where she ultimately held the role of
Senior Manager of Business Assurance for Consumer Products,
Manufacturing, and Middle Market industries. Ms. Pankovcin earned
her B.S. in Accounting from Dowling College and her Master’s Degree
in Business Administration from Hofstra University. She is a
Certified Public Accountant.
Serving as Controller since October 2020 and Principal
Accounting Officer since March 2021 at Aditxt, Mr. Farley worked
closely with Ms. Pankovcin on all aspects of public company
management and SEC reporting. Prior to joining Aditxt, Mr. Farley
was the Senior Controller and Treasurer of Business Development
Corporation of America and was the Senior Controller of Blackrock
Capital Investment Corporation (Nasdaq: BKCC). Before joining
BlackRock, Mr. Farley was a Senior Controller for PineBridge
Investments. He began his career with PricewaterhouseCoopers LLP.
Mr. Farley earned his B.S. in Accounting from Long Island
University. He is a Certified Public Accountant.
“As Aditxt grows and positions toward a global footprint, we are
fortunate to have internal management talent who can move into key
executive positions ready to implement our growth strategy. Corinne
has proved her business acumen and effectiveness through our Nasdaq
listing and beyond. As President, she’ll work closely with me on
all aspects of our business’ scaleup across the board,” stated
Aditxt Co-Founder, Chairman, and CEO Amro Albanna. “We are very
fortunate to have Tom, who is extremely well qualified, to step
into the CFO role based on his extensive experience in financial
management of publicly traded companies and in auditing companies
including the biopharma sector. I look forward to working with both
Corinne and Tom in their new roles.”
About Aditxt: Aditxt is
developing technologies specifically focused on improving the
health of the immune system through immune monitoring and
reprogramming. Aditxt’s immune monitoring technology is designed to
provide a personalized comprehensive profile of the immune system.
Aditxt’s immune reprogramming technology is currently at the
pre-clinical stage and is designed to retrain the immune system to
induce tolerance with an objective of addressing rejection of
transplanted organs, autoimmune diseases, and allergies. For more
information, please visit: www.aditxt.com
Forward-Looking Statements Certain statements in this
press release constitute “forward-looking statements” within the
meaning of federal securities laws. Forward looking statements
include statements regarding the Company’s intentions, beliefs,
projections, outlook, analyses or current expectations concerning,
among other things, the Company’s ongoing and planned product and
business development; the Company’s intellectual property position;
the Company’s ability to develop commercial functions; expectations
regarding product launch and revenue; the Company’s results of
operations, cash needs, spending, financial condition, liquidity,
prospects, growth and strategies; the industry in which the Company
operates; and the trends that may affect the industry or the
Company. Forward-looking statements are not guarantees of future
performance and actual results may differ materially from those
indicated by these forward-looking statements as a result of
various important factors, as well as those risks more fully
discussed in the section titled “Risk Factors” in the Company’s
most recent Annual Report on Form 10-K, as well as discussions of
potential risks, uncertainties, and other important factors in the
Company’s other filings with the Securities and Exchange
Commission. All such statements speak only as of the date made, and
the Company undertakes no obligation to update or revise publicly
any forward-looking statements, whether as a result of new
information, future events or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210927005469/en/
Media and Investor Relations Contact: Aditxt, Inc.
ir@aditxt.com
Aditxt (NASDAQ:ADTX)
Historical Stock Chart
From May 2024 to Jun 2024
Aditxt (NASDAQ:ADTX)
Historical Stock Chart
From Jun 2023 to Jun 2024